We found that the development of high fasting blood sugar (Figure 4B), impaired glucose tolerance at 12 weeks after STZ (Figure 4C) and low serum insulin content at 12 weeks after STZ (Figure 4D) in STZ+BIX mice was not different from STZ mice. The gene discussed is INS; the disease is Impaired glucose tolerance.